| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | chlorhexidine gluconate | FAERS: 8 | US FAERS | |
| 2 | Prednisone | FAERS: 6 | US FAERS | |
| 3 | 2-[(E)-[1-(2-Amino-1,3-thiazol-4-yl)-2-[[(2S,3S)-2-methyl-4-oxo-1-sulfoazetidin-3-yl]amino]-2-oxoethylidene]amino]oxy-2-methylpropanoic acid;(2S)-2,6-diaminohexanoic acid | FAERS: 4 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 4 | Palonosetron | FAERS: 4 | US FAERS | |
| 5 | Ondansetron | FAERS: 2 | US FAERS | |
| 6 | Prednisolone | FAERS: 2 | US FAERS | |
| 7 | Tobramycin | FAERS: 2 | US FAERS | |
| 8 | lumacaftor, ivacaftor drug combination | FAERS: 2 | US FAERS | |
| 9 | Cyproheptadine hydrochloride | FAERS: 1 | US FAERS | |
| 10 | Cyproheptadine | FAERS: 1 | US FAERS | |
| 11 | Senna Extract | FAERS: 1 | US FAERS | |
| 12 | ferrous sulfate | FAERS: 1 | US FAERS |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120241
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.